Companies
/Healthcare
Stryker Corp
$317.54
▲ $6.82 (+2.19%) today
Markets closed · 3:07am ET
Stryker (SYK) Earnings History & Trends
86%
EPS beat rate
+7.39%
Avg. EPS surprise
Consecutive EPS misses
SYK vs Market · 30-day return after each reportSYKS&P 500
SYK EPS Trend · estimate vs actualEstimateActual
SYK Revenue Trend · estimate vs actualEstimateActual
How Often Does Stryker Beat Earnings Estimates?
Stryker beat EPS estimates in 6 of its last 7 reported quarters.
| Quarter | EPS · est. | Surprise | Revenue · est. | Surprise |
|---|---|---|---|---|
| Q3 2026 Adjusted EPS excludes a $293 million goodwill impairment ($0.76 per share), $175 million amortization of purchased intangibles ($0.37), $153 million structural optimization and other special charges incl. $77 million Spinal Implants sale related ($0.20), $32 million regulatory and legal matters ($0.07), and $50 million tax matters ($0.11). GAAP diluted EPS was $1.96. | $3.52 est. $3.55 | −0.78% | $6.5B est. $6.6B | −1.47% |
| Q2 2026 | $3.69 est. $3.49 | +5.79% | $6.6B est. $6.6B | +0.15% |
| Q1 2026 | $2.60 est. $2.27 | +14.54% | $6.0B est. $6.3B | −4.89% |
| Q4 2025 | $4.47 est. $4.40 | +1.59% | $7.2B est. $7.1B | +0.98% |
| Q3 2025 | $3.19 est. $2.56 | +24.61% | $6.1B est. $6.0B | +0.20% |
| Q2 2025 | $3.13 est. $3.07 | +1.95% | $6.0B est. $5.9B | +1.57% |
| Q1 2025 | $2.84 est. $2.73 | +4.03% | $5.9B est. $5.7B | +3.07% |
Figures from SEC filings and company reports. Not investment advice.